{"drugs":["Malathion","Ovide"],"mono":{"0":{"id":"355405-s-0","title":"Generic Names","mono":"Malathion"},"1":{"id":"355405-s-1","title":"Dosing and Indications","sub":{"0":{"id":"355405-s-1-4","title":"Adult Dosing","mono":"<b>Pediculosis capitis, Infection of the scalp hair:<\/b> apply lotion on dry hair in amount just sufficient to thoroughly wet the hair and scalp; allow hair to dry; after 8-12 hours, shampoo hair, rinse, and use a fine-toothed (nit) comb to remove dead lice and eggs; if lice are still present after 7-9 days, repeat with second application "},"1":{"id":"355405-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>Safety and effectiveness in children less than 6 years of age has not been established<\/li><li><b>Pediculosis capitis, Infection of the scalp hair:<\/b> (age 6 years and older) apply lotion on dry hair in amount just sufficient to thoroughly wet the hair and scalp; allow hair to dry; after 8-12 hours, shampoo hair, rinse, and use a fine-toothed (nit) comb to remove dead lice and eggs; if lice are still present after 7-9 days, repeat with second application<\/li><\/ul>"},"3":{"id":"355405-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Pediculosis capitis, Infection of the scalp hair<br\/><b>Non-FDA Labeled Indications<\/b><br\/>Scabies<br\/>"}}},"3":{"id":"355405-s-3","title":"Contraindications\/Warnings","sub":[{"id":"355405-s-3-9","title":"Contraindications","mono":"<ul><li>hypersensitivity to malathion or any component of the product<\/li><li>infants; possible increased drug absorption<\/li><li>neonates; possible increased drug absorption<\/li><\/ul>"},{"id":"355405-s-3-10","title":"Precautions","mono":"<ul><li>chemical burns, including second-degree burns, and stinging sensations may occur<\/li><li>flammable; do not expose lotion or wet hair to open flame, electric heat sources, or smoking<\/li><li>skin irritation may occur; interruption or discontinuation of therapy may be warranted<\/li><\/ul>"},{"id":"355405-s-3-11","title":"Pregnancy Category","mono":"<ul><li>B (FDA)<\/li><li>B2 (AUS)<\/li><\/ul>"},{"id":"355405-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"355405-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Application site irritation, Skin irritation<br\/><b>Serious<\/b><br\/><b>Dermatologic:<\/b>Chemical burn<br\/>"},"6":{"id":"355405-s-6","title":"Drug Name Info","sub":{"0":{"id":"355405-s-6-17","title":"US Trade Names","mono":"Ovide<br\/>"},"2":{"id":"355405-s-6-19","title":"Class","mono":"<ul><li>Organophosphate<\/li><li>Pediculicide<\/li><\/ul>"},"3":{"id":"355405-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"355405-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"355405-s-7","title":"Mechanism Of Action","mono":"Topical: Malathion acts via cholinesterase inhibition. It exerts both lousicidal and ovicidal actions  in vitro.<br\/>"},"8":{"id":"355405-s-8","title":"Pharmacokinetics","sub":[{"id":"355405-s-8-23","title":"Absorption","mono":"Topical: 8%<br\/>"}]},"9":{"id":"355405-s-9","title":"Administration","mono":"<b>Topical<\/b><br\/><ul><li>use only on scalp hair; avoid contact with eyes<\/li><li>apply to dry hair using only the amount needed to thoroughly wet the hair and scalp; pay particular attention to the back of the head and neck<\/li><li>allow hair to dry naturally (use no electric heat source and allow hair to remain uncovered)<\/li><\/ul>"},"10":{"id":"355405-s-10","title":"Monitoring","mono":"presence of lice<br\/>"},"11":{"id":"355405-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Topical Lotion: 0.5 %<br\/><\/li><li><b>Ovide<\/b><br\/>Topical Lotion: 0.5 %<br\/><\/li><\/ul>"},"13":{"id":"355405-s-13","title":"Clinical Teaching","mono":"<ul><li>Lotion is flammable. Patient should not expose lotion and wet hair to open flames or electric heat sources (eg, hair dryers, curling irons). Advise patient not to smoke when applying lotion or while hair is wet.<\/li><li>This drug may cause skin irritation, stinging, or burns (including second degree).<\/li><li>Instruct patient to report persistent eye irritation or visual changes following accidental eye exposure.<\/li><li>Advise patient to suspend use with skin irritation (until clear), and to report recurrence of skin irritation following a secondary application.<\/li><li>Patient should avoid drug contact with eyes.<\/li><li>Tell patient that drug should be used only on scalp hair.<\/li><li>Instruct patient to allow hair to dry naturally and to leave hair uncovered following application.<\/li><\/ul>"}}}